Box jellyfish of the Chironex species are among the most venomous animals in the world, capable of killing humans with their sting. Their venom, though, which kills by rapidly punching holes in human red blood cells, can be slowed down by administering zinc, according to research published December 12 in the open access journal PLOS ONE by Angel Yanagihara from the University of Hawaii and colleagues.
The researchers developed ways to extract venom from the jellyfish, and tested it on human blood and on mice. They found that the venom created pores in human red blood cells, making them leak large amounts of potassium, which causes cardiac arrest and death.
As Yanagihara elaborates, "For over 60 years researchers have sought to understand the horrifying speed and potency of the venom of the Australian box jellyfish, arguably the most venomous animal in the world. We have found that a previously disregarded hemolysin can cause an avalanche of reactions in cells. This includes an almost instantaneous, massive release of potassium that can cause acute cardiovascular collapse and death."
The authors treated the cells with a zinc compound which inhibits this process, and found that the treatment could slow the pore-forming process in cells, and increased survival times in the mice treated with the compound, zinc gluconate. The research suggests that the venom's capacity to increase potassium levels is what makes it so dangerous, and that rapid administration of zinc may be a potential life-saver in human sting victims.
Yanagihara AA, Shohet RV (2012) Cubozoan Venom-Induced Cardiovascular Collapse Is Caused by Hyperkalemia and Prevented by Zinc Gluconate in Mice. PLoS ONE 7(12): e51368. doi:10.1371/journal.pone.0051368
Public Library of Science: http://www.plos.org
This press release was posted to serve as a topic for discussion. Please comment below. We try our best to only post press releases that are associated with peer reviewed scientific literature. Critical discussions of the research are appreciated. If you need help finding a link to the original article, please contact us on twitter or via e-mail.
Trial will involve 56 patients with metastatic lung cancer who will undergo treatment using genetically modified bone marrow stem cells
Narcissism has long afflicted more men than women—but that could be changing
Research shows that only 1 in 5 five people takes a break and leaves his desk to eat. Most workers are simply eating at their desks. But creativity can take a big hit without a change of scenery.
A Mirror Online report on a breast cancer patient who refused medical treatment for so-called natural alternatives ignores the health risks
From Adam and Eve to Snakes on a Plane, legend and pop culture confirms all that slithers is just a little bit creepy. Andrew McGibbon has made it his mission to change people’s minds, highlighting snakes’ beauty and elegance in his series Slitherstition.
Just a rash? Not if you have eczema. People with eczema often have a hard time finding appropriate health care and are apt to miss work dealing with the chronic skin problem, a study finds.
The technique aims to rejuvenate a woman's eggs using mitochondria from cells extracted from her ovaries. A Toronto clinic's first births are due soon, and some doctors are worried about side effects.
Findings published in The Lancet show chance of heart attack drops by 48% when people most at risk take cholesterol-lowering medications
Paranoid fears are common and have a variety of causes but new research shows specific issue cognitive behaviour therapy can bring significant benefits
Popular belief has it that human ‘sex pheromones’ exist and are well-established by the scientific community. But all is not as it seems, as Tristram Wyatt explains